Updated 5-year survival and exploratory T x N subset analyses of ACTS-CC trial: a randomised controlled trial of S-1 versus tegafur-uracil/leucovorin as adjuvant chemotherapy for stage III colon cancer

OBJECTIVE: Adjuvant Chemotherapy Trial of TS-1 for Colon Cancer (ACTS-CC), a randomised phase III trial, demonstrated that adjuvant therapy with S-1 for stage III colon cancer was non-inferior in 3-year disease-free survival (DFS) to that of tegafur-uracil plus leucovorin (UFT/LV). We updated DFS an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kusumoto, Tetsuya, Ishiguro, Megumi, Nakatani, Eiji, Yoshida, Motoki, Inoue, Tsukasa, Nakamoto, Yoshihiko, Shiomi, Akio, Takagane, Akinori, Sunami, Eiji, Shinozaki, Hiroharu, Takii, Yasumasa, Maeda, Atsuyuki, Ojima, Hitoshi, Hashida, Hiroki, Mukaiya, Mitsuhiro, Yokoyama, Tadashi, Nakamura, Masato, Munemoto, Yoshinori, Sugihara, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212676/
https://www.ncbi.nlm.nih.gov/pubmed/30425843
http://dx.doi.org/10.1136/esmoopen-2018-000428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212676/
https://www.ncbi.nlm.nih.gov/pubmed/30425843
http://dx.doi.org/10.1136/esmoopen-2018-000428

Ejemplares similares